Delayed Vaccine Rollout Complicates Global Response to Mpox Outbreak
Vaccines intended to combat the growing Mpox outbreak are experiencing significant delays, possibly lasting several months. Supply chain problems and manufacturing constraints are major obstacles to swift vaccine distribution. This delay hinders the global efforts to control the virus, which is spreading rapidly and poses severe health risks.